AR037594A1 - METHODS TO TREAT BACTERIAL INFECTIONS IN DOGS AND CATS - Google Patents

METHODS TO TREAT BACTERIAL INFECTIONS IN DOGS AND CATS

Info

Publication number
AR037594A1
AR037594A1 ARP020104593A ARP020104593A AR037594A1 AR 037594 A1 AR037594 A1 AR 037594A1 AR P020104593 A ARP020104593 A AR P020104593A AR P020104593 A ARP020104593 A AR P020104593A AR 037594 A1 AR037594 A1 AR 037594A1
Authority
AR
Argentina
Prior art keywords
cats
bacterial infections
dogs
methods
treat bacterial
Prior art date
Application number
ARP020104593A
Other languages
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0130694.3A external-priority patent/GB0130694D0/en
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR037594A1 publication Critical patent/AR037594A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Tratamiento de una variedad de infecciones bacteriana en animales de companía, en particular perros y gatos con un derivado de beta-lactama, compuesto de fórmula (1). Composiciones farmacéuticas de un compuesto de fórmula (1): en la que R1 es H, un catión de una sal farmacéuticamente aceptable, o un grupo hidrolizable en vivo capaz de general CO2H, y R2 es alquilo de C1-4, y un diluyente o vehículo farmacéutico.Treatment of a variety of bacterial infections in companion animals, in particular dogs and cats with a beta-lactam derivative, compound of formula (1). Pharmaceutical compositions of a compound of formula (1): wherein R1 is H, a cation of a pharmaceutically acceptable salt, or a live hydrolyzable group capable of general CO2H, and R2 is C1-4 alkyl, and a diluent or pharmaceutical vehicle

ARP020104593A 2001-12-21 2002-11-28 METHODS TO TREAT BACTERIAL INFECTIONS IN DOGS AND CATS AR037594A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0130694.3A GB0130694D0 (en) 2001-12-21 2001-12-21 Treatment
US35996102P 2002-02-27 2002-02-27
US39893302P 2002-07-26 2002-07-26

Publications (1)

Publication Number Publication Date
AR037594A1 true AR037594A1 (en) 2004-11-17

Family

ID=27256361

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020104593A AR037594A1 (en) 2001-12-21 2002-11-28 METHODS TO TREAT BACTERIAL INFECTIONS IN DOGS AND CATS

Country Status (12)

Country Link
EP (1) EP1455900A1 (en)
JP (1) JP2005524611A (en)
CN (1) CN1606463A (en)
AR (1) AR037594A1 (en)
AU (1) AU2002348985A1 (en)
BR (1) BR0215070A (en)
CA (1) CA2470995A1 (en)
IL (1) IL162103A0 (en)
NO (1) NO20043008L (en)
PL (1) PL370624A1 (en)
TW (1) TW200301126A (en)
WO (1) WO2003053522A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1740214B1 (en) * 2004-04-22 2007-10-03 Pfizer Products Incorporated Method of stabilizing disordered cefovecin sodium salt

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0395219T3 (en) * 1989-03-30 1999-02-15 Pfizer Cephalosporins and their homologs, methods of their preparation and pharmaceutical preparations
GB9424847D0 (en) * 1994-12-09 1995-02-08 Smithkline Beecham Plc Novel process
GB2300856A (en) * 1995-05-16 1996-11-20 Pfizer Ltd Beta-lactam preparation

Also Published As

Publication number Publication date
WO2003053522A1 (en) 2003-07-03
EP1455900A1 (en) 2004-09-15
TW200301126A (en) 2003-07-01
JP2005524611A (en) 2005-08-18
CN1606463A (en) 2005-04-13
PL370624A1 (en) 2005-05-30
IL162103A0 (en) 2005-11-20
BR0215070A (en) 2004-11-09
NO20043008L (en) 2004-09-01
AU2002348985A1 (en) 2003-07-09
CA2470995A1 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
AR037595A1 (en) METHODS OF TREATMENT AND FORMULATIONS OF CEPHALOSPORINE
EA200501098A1 (en) ANTIBACTERIAL AGENTS
BR9915208A (en) Pharmaceutical preparation of moxifloxacin
EA200100623A1 (en) KETOLID ANTIBIOTICS
EA200100416A1 (en) 13-MEMBER AZALIDES AND THEIR APPLICATION AS ANTIBIOTIC AGENTS
BR9808290A (en) Compound, pharmaceutical composition, process of treating bacterial infections in humans and animals, use of a compound, and, process for its preparation
ATE496048T1 (en) PHENYLCARBOXAMIDE COMPOUNDS FOR PAIN TREATMENT
ATE194987T1 (en) SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE
RU94008616A (en) 2-THIOSUBLISHED CARBAPENES, INTERMEDIATE CONNECTIONS FOR OBTAINING, METHODS OF OBTAINING, PHARMACEUTICAL COMPOSITION, METHOD OF TREATING BACTERIAL INFECTIONS
ATE268337T1 (en) C11-CARBAMATES OF ANTIBACTERIAL MACROLIDS
TR200400630T4 (en) Ketolite antibiotics
NO923200L (en) Piperidino derivatives
AR037594A1 (en) METHODS TO TREAT BACTERIAL INFECTIONS IN DOGS AND CATS
BR0006301A (en) Antibacterial and prokinetic macrolides
ID22543A (en) CARBAPENEM COMPOUNDS, USES AND COMPOUNDS
BR9915639A (en) Use of phosphonoformic acid derivatives to treat infections
PT1167376E (en) MACROLIDOS ANTIBIOTICS
BR0308118A (en) Method For Treating Osteoarthritis
DE3775823D1 (en) PHARMACEUTICAL PREPARATION FOR TREATING BACTERIAL INFECTIONS.
ATE361063T1 (en) BREEDING METHOD AND FEED
GB0003234D0 (en) Method of treatment
BR0007491A (en) Use of 3-isoxazolidinones and hydroxylamic acids to treat infections
EA200100768A1 (en) APPLICATION OF 3-ISOXASOZOLIDINONES AND HYDROXYAMINO ACIDS FOR THE TREATMENT OF INFECTIONS
EA200200413A1 (en) PROCARE OF HYGROMYCIN A
ECSP003482A (en) IMMUNOPOTENTIATING AGENTS

Legal Events

Date Code Title Description
FB Suspension of granting procedure